DALLAS, Sept. 4, 2019 /PRNewswire/ -- Richie Jaynes is proud to announce his newest venture. 

EWING, N.J., Sept. 4, 2019 /PRNewswire/ -- GS1 US® has published a new Implementation Guideline titled

ROCKVILLE, Md., Sept. 4, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate update at The Fall Investor Sum

AUBURN, Calif., Sept. 4, 2019 /PRNewswire/ -- TCS Healthcare Technologies (TCS), a leading provider of population health and managed care software, is pleased to announce that Matt Fahner has been appointed Vice President of Engineering. In this new role, Mr. Fahner will oversee the development of all TCS products.

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Grant Avenue Capital, LLC, www.GrantAveCap.com, a New York-based healthcare-focused private equity firm, announ

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Roughly 133 million Americans live with chronic health conditions, struggling in varying degrees with everyday life and yearning for support and community. This is why Healthline Media, the

SAN CARLOS, Calif., Sept. 4, 2019 /PRNewswire/ -- Natera, Inc. (NAS

REDWOOD CITY, Calif., Sept. 4, 2019 /PRNewswire/ -- Bolt Biotherapeutics, Inc., a private biotechnology company focused on unleashing the power of the immune system to treat cancer, today announced that it has appointed Randall Schatzman, Ph.D. to the position of chief executive officer and as a member of Bolt's board of directors. Dr. Scha

WASHINGTON, Sept. 4, 2019 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to announce that Giovanni Caforio, M.D., chairman and CEO of Bristol-Myers Squibb has assumed the role of chairman of the PhRMA board of directors.

ST. LOUIS, Sept. 4, 2019 /PRNewswire/ -- Bayer has awarded